#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	18250	16S	1529	1529	99.93	16S.l15.c4.ctg.1	3069	732.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	2216	2216	T	1143	T,G,A	1140,2,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	18250	16S	1529	1529	99.93	16S.l15.c4.ctg.1	3069	732.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1950	1950	C	1140	C,A,G	1137,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30600	23S	2890	2890	99.93	23S.l15.c30.ctg.1	4254	896.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	2079	2079	A	1196	A	1196	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30600	23S	2890	2890	99.93	23S.l15.c30.ctg.1	4254	896.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2713	2713	C	1060	C	1060	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30600	23S	2890	2890	99.93	23S.l15.c30.ctg.1	4254	896.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2787	2787	A	983	A,G,T	978,2,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30600	23S	2890	2890	99.93	23S.l15.c30.ctg.1	4254	896.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3339	3339	C	1099	C,T,G,A	1093,3,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	G5V	NONSYN	13	15	GGT	597	599	GTT	156;154;154	G;T,G;T	156;153,1;154	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	E12K	NONSYN	34	36	GAA	618	620	AAA	167;166;165	A;A;A	167;165;164	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	F31L	NONSYN	91	93	TTT	675	677	TTG	204;204;207	T;T;G	203;204;207	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	708	710	CAA	240;241;241	C,A;A;A,G	239,1;241;240,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	S75P	NONSYN	223	225	TCC	807	809	CCT	216;220;222	C,G;C,A;T	214,1;218,1;221	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	V87A	NONSYN	259	261	GTA	843	845	GCA	195;195;198	G;C;A,C	195;195;197,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	V130L	NONSYN	388	390	GTC	972	974	CTC	240;242;242	C;T,A;C,A	240;241,1;241,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	R135C	NONSYN	403	405	CGC	987	989	TGT	250;246;248	T,C;G;T	249,1;246;248	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	T137A	NONSYN	409	411	ACG	993	995	GCG	255;254;253	G;C,A;G	255;253,1;253	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1035	1037	AAG	269;267;267	A;A;G,A	269;267;266,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1038	1040	AAT	268;271;272	A,G,C;A,C;T,C	265,2,1;270,1;271,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1236	1238	TTG	158;158;158	T;T;G,A	158;158;157,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1266	1268	AGC	144;144;145	A;G;C	144;144;145	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1335	1337	CTG	150;150;148	C;T;G	150;150;148	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1341	1343	TCC	143;145;145	T;C,G;C	143;144,1;145	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1356	1358	GTG	169;170;170	G,T;T,G;G	167,2;169,1;170	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1994	folP	852	852	93.78	folP.l15.c4.ctg.1	2046	121.5	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1407	1409	GCG	209;208;207	G,C;C,A,T;G	208,1;206,1,1;207	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6464	gyrA	2751	2751	100.0	gyrA.l6.c17.ctg.1	3869	208.3	1	SNP	p	S91F	0	.	.	271	273	TCC	828	830	TCC	253;255;259	T,C;C;C	252,1;255;259	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6464	gyrA	2751	2751	100.0	gyrA.l6.c17.ctg.1	3869	208.3	1	SNP	p	D95G	0	.	.	283	285	GAC	840	842	GAC	259;258;261	G;A;C	259;258;261	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6464	gyrA	2751	2751	100.0	gyrA.l6.c17.ctg.1	3869	208.3	1	SNP	p	D95N	0	.	.	283	285	GAC	840	842	GAC	259;258;261	G;A;C	259;258;261	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	531	2324	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1863	155.0	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	934	934	T	250	T,G	249,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1410	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1311	132.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5838	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3575	203.4	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1712	1714	ATC	250;251;255	A,G;T,G;C	249,1;250,1;255	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5838	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3575	203.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1865	1867	GCA	302;301;303	G;C;A,T	302;301;302,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5838	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3575	203.4	1	SNP	p	D86N	0	.	.	256	258	GAC	818	820	GAC	219;222;223	G,T;A;C	218,1;221;223	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5838	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3575	203.4	1	SNP	p	S87R	0	.	.	259	261	AGT	821	823	AGT	225;224;228	A,G;G;T	224,1;224;228	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5838	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3575	203.4	1	SNP	p	S87I	0	.	.	259	261	AGT	821	823	AGT	225;224;228	A,G;G;T	224,1;224;228	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5838	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3575	203.4	1	SNP	p	S87W	0	.	.	259	261	AGT	821	823	AGT	225;224;228	A,G;G;T	224,1;224;228	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5838	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3575	203.4	1	SNP	p	S88P	0	.	.	262	264	TCC	824	826	TCC	226;227;233	T,G;C,T;C	225,1;225,1;232	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5184	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3157	204.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1785	1787	GGC	291;293;291	G,T;G;C	289,1;291;289	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	5038	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2966	211.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1600	1602	GCA	313;315;314	G,A,C;C,G;A	310,2,1;314,1;314	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	5038	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2966	211.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1603	1605	ATC	314;313;310	A;T;C	314;313;310	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	5038	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2966	211.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1615	1617	GTG	321;324;326	G;T;G,C,A	321;324;322,2,2	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	5038	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2966	211.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1615	1617	GTG	321;324;326	G;T;G,C,A	321;324;322,2,2	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	5038	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2966	211.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2119	2121	ACC	293;294;292	A;C;C,T	293;294;291,1	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	5038	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2966	211.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2173	2175	GCG	270;271;273	G;C;G,T	270;271;272,1	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	5038	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2966	211.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2173	2175	GCG	270;271;273	G;C;G,T	270;271;272,1	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	5038	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2966	211.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2296	2298	GGT	275;276;277	G;G;T	275;276;277	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	5038	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2966	211.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2305	2307	GGC	283;278;280	G;G;C	283;278;280	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	5038	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2966	211.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2323	2325	CCG	272;275;273	C,G,A;C;G,A	270,1,1;275;272,1	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6770	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3669	230.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2984	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2367	156.9	0	.	p	.	0	S22G	NONSYN	64	66	AGC	664	666	GGC	207;202;204	G,A;G;C	205,2;202;204	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2984	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2367	156.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	846	846	C	241	C	241	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	H217N	NONSYN	649	651	CAT	782	784	AAT	5;5;5	A;A;T	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	D218N	NONSYN	652	654	GAT	785	787	AAT	5;5;5	A;A;T	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	A222V	NONSYN	664	666	GCT	797	799	GTT	4;3;3	G;T;T	4;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	V226A	NONSYN	676	678	GTA	809	811	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	.	MULTIPLE	700	702	ACT	832	834	GTA	2;2;3	G;T;A	2;2;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	S236N	NONSYN	706	708	AGC	838	840	AAC	4;5;5	A;A;C	4;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	.	MULTIPLE	709	711	AAC	842	846	TGGCG	5;5;5;5;5	T;G;G;C;G	5;5;5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	D238A	NONSYN	712	714	GAT	848	850	GCT	6;6;6	G;C;T	6;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	908	910	TTA	40;43;45	T;T;A	40;43;45	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	953	955	CAT	74;74;74	C;A,C;T	74;73,1;74	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	956	958	AGT	74;74;74	A;G;T	74;74;74	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	386	porB1a	984	292	90.2	porB1a.l6.c30.ctg.1	1049	34.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	965	967	TAC	72;72;72	T;A;C	72;72;72	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	G38E	NONSYN	112	114	GGA	542	544	GAA	308;312;315	G;A;A,G,T	308;312;312,2,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	T87A	NONSYN	259	261	ACT	689	691	GCT	276;278;278	G,A,T;C;T,G	273,1,1;277;277,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	695	697	AGC	279;276;278	A,G;G,T;C,T	278,1;275,1;277,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	.	MULTIPLE	358	359	AA	787	788	CG	274;274	C,A;G,T	273,1;273,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	.	MULTIPLE	361	362	GA	790	792	CAG	278;278;278	C;A,T;GC,G	278;277,1;265,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	N122K	NONSYN	364	366	AAC	794	796	AAA	274;276;274	A,C;A,G;A,C	273,1;274,2;272,2	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	K143E	NONSYN	427	429	AAA	857	859	GAA	313;318;316	G;A,T;A,G	313;317,1;315,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	V151A	NONSYN	451	453	GTA	881	883	GCA	323;323;324	G;C,G;A	323;322,1;324	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	N212D	NONSYN	634	636	AAT	1064	1066	GAT	321;319;318	G;A;T	321;319;318	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	D213G	NONSYN	637	639	GAT	1067	1069	GGT	312;311;310	G;G,A;T	312;310,1;310	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1082	1084	ATG	297;299;295	A,G;T;G	296,1;299;295	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	0	.	p	.	0	D333E	NONSYN	997	999	GAC	1427	1429	GAA	303;304;307	G;A;A	303;304;307	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	1	SNP	p	G120K	1	.	.	358	360	AAG	787	789	CGG	274;274;273	C,A;G,T;G,T	273,1;273,1;272,1	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	1	SNP	p	A121D	1	.	.	361	363	GAC	790	793	CGC	278;278;273	C;GC,G;C	278;265,1;273	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	3578	porB1b	1047	1047	98.09	porB1b.l15.c30.ctg.1	1611	264.6	1	SNP	p	D121N	0	.	.	361	363	GAC	790	793	CGC	278;278;273	C;GC,G;C	278;265,1;273	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12452	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5371	288.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1676	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1588	131.4	1	SNP	p	V57M	1	.	.	169	171	ATG	794	796	ATG	309;309;306	A,T;T;G	308,1;309;306	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
